BTVPUR AlSap 1

RSS

Withdrawn

This medicine's authorisation has been withdrawn

bluetongue-virus serotype-1 antigen
MedicineVeterinaryWithdrawn

Lithuanian is available via eTranslation, the European Commission's machine translation service.

Translate to Lithuanian | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for BTVPUR AlSap 1 has been withdrawn at the request of the marketing-authorisation holder.

български (BG) (273.86 KB - PDF)

Rodyti

español (ES) (219.81 KB - PDF)

Rodyti

čeština (CS) (279.88 KB - PDF)

Rodyti

dansk (DA) (215.41 KB - PDF)

Rodyti

Deutsch (DE) (241.24 KB - PDF)

Rodyti

eesti (ET) (244.85 KB - PDF)

Rodyti

ελληνικά (EL) (281.98 KB - PDF)

Rodyti

français (FR) (242.72 KB - PDF)

Rodyti

italiano (IT) (215.09 KB - PDF)

Rodyti

latviešu (LV) (257.92 KB - PDF)

Rodyti

lietuvių (LT) (242.99 KB - PDF)

Rodyti

magyar (HU) (257.59 KB - PDF)

Rodyti

Malti (MT) (287.39 KB - PDF)

Rodyti

Nederlands (NL) (215.61 KB - PDF)

Rodyti

polski (PL) (262.68 KB - PDF)

Rodyti

português (PT) (215.81 KB - PDF)

Rodyti

română (RO) (264.84 KB - PDF)

Rodyti

slovenčina (SK) (263.85 KB - PDF)

Rodyti

slovenščina (SL) (271.89 KB - PDF)

Rodyti

suomi (FI) (214.4 KB - PDF)

Rodyti

svenska (SV) (215.45 KB - PDF)

Rodyti

Product information

български (BG) (1.59 MB - PDF)

Rodyti

español (ES) (959.08 KB - PDF)

Rodyti

čeština (CS) (1.31 MB - PDF)

Rodyti

dansk (DA) (976.46 KB - PDF)

Rodyti

Deutsch (DE) (1.05 MB - PDF)

Rodyti

eesti (ET) (962.08 KB - PDF)

Rodyti

ελληνικά (EL) (1.63 MB - PDF)

Rodyti

français (FR) (969.67 KB - PDF)

Rodyti

hrvatski (HR) (995.44 KB - PDF)

Rodyti

italiano (IT) (409.73 KB - PDF)

Rodyti

latviešu (LV) (588.19 KB - PDF)

Rodyti

lietuvių (LT) (480.92 KB - PDF)

Rodyti

magyar (HU) (1.31 MB - PDF)

Rodyti

Malti (MT) (596.85 KB - PDF)

Rodyti

Nederlands (NL) (355.82 KB - PDF)

Rodyti

polski (PL) (595.12 KB - PDF)

Rodyti

português (PT) (421.48 KB - PDF)

Rodyti

română (RO) (479.93 KB - PDF)

Rodyti

slovenčina (SK) (582.8 KB - PDF)

Rodyti

slovenščina (SL) (563.67 KB - PDF)

Rodyti

suomi (FI) (942.5 KB - PDF)

Rodyti

svenska (SV) (419.01 KB - PDF)

Rodyti

Íslenska (IS) (1.21 MB - PDF)

Rodyti

norsk (NO) (410.45 KB - PDF)

Rodyti
Latest procedure affecting product information:R/0005
08/09/2015

български (BG) (237.24 KB - PDF)

Rodyti

español (ES) (179.61 KB - PDF)

Rodyti

čeština (CS) (214.8 KB - PDF)

Rodyti

dansk (DA) (168.71 KB - PDF)

Rodyti

Deutsch (DE) (181.32 KB - PDF)

Rodyti

eesti (ET) (216.18 KB - PDF)

Rodyti

ελληνικά (EL) (224.9 KB - PDF)

Rodyti

français (FR) (168.45 KB - PDF)

Rodyti

hrvatski (HR) (203.36 KB - PDF)

Rodyti

italiano (IT) (166.05 KB - PDF)

Rodyti

latviešu (LV) (222.44 KB - PDF)

Rodyti

lietuvių (LT) (215.2 KB - PDF)

Rodyti

magyar (HU) (208.44 KB - PDF)

Rodyti

Malti (MT) (226.37 KB - PDF)

Rodyti

Nederlands (NL) (169.29 KB - PDF)

Rodyti

polski (PL) (215.44 KB - PDF)

Rodyti

português (PT) (180.94 KB - PDF)

Rodyti

română (RO) (212.26 KB - PDF)

Rodyti

slovenčina (SK) (211.23 KB - PDF)

Rodyti

slovenščina (SL) (210.68 KB - PDF)

Rodyti

suomi (FI) (168.59 KB - PDF)

Rodyti

svenska (SV) (168.12 KB - PDF)

Rodyti

Íslenska (IS) (171.81 KB - PDF)

Rodyti

norsk (NO) (166.89 KB - PDF)

Rodyti

Product details

Name of medicine
BTVPUR AlSap 1
Active substance
bluetongue-virus serotype-1 antigen
International non-proprietary name (INN) or common name
bluetongue-virus serotype-1 antigen
Species
  • Sheep
  • Cattle
Anatomical therapeutic chemical veterinary (ATCvet) code
QI04AA02

Pharmacotherapeutic group

Immunologicals

Therapeutic indication

Active immunisation of sheep and cattle to prevent viraemia and to reduce clinical signs caused by bluetongue virus serotype 1.

Onset of immunity has been demonstrated three weeks after the primary vaccination course. The duration of immunity for cattle and sheep is one year after the primary vaccination course.

Authorisation details

EMA product number
EMEA/V/C/002230
Marketing authorisation holder
Merial

29 Avenue Tony Garnier
69007 Lyon
France

Marketing authorisation issued
17/12/2010
Revision
4

Assessment history

This page was last updated on

Share this page